IP Library Granted Patent US 9,933,442
Granted Patent B2
US 9,933,442 · App. 14/508,993 · Granted Apr 3, 2018

Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,933,442
App. No.
14/508,993
Granted
Apr 3, 2018
Kind
B2
Abstract

A monoclonal antibody that does not show a crossreactivity with middle-molecular weight (MMW) adiponectin and specifically reacts with high-molecular weight (HMW) adiponectin alone is disclosed. The monoclonal antibody of the present invention can be produced by using HMW adiponectin as an antigen. According to the monoclonal antibody of the present invention, a convenient, high-accurate, and versatile reagent for analyzing HMW adiponectin can be provided.

Claims (9)

1. A method for producing a monoclonal antibody, the method comprising:

immunizing a non-human animal with an antigen consisting of high-molecular weight adiponectin purified from human blood, together with an adjuvant;

producing hybridomas using cells from the immunized non-human animal; and

selecting a hybridoma which produces a monoclonal antibody which reacts with high-molecular weight adiponectin, does not react with trimeric adiponectin, and does not substantially react with hexameric adiponectin, when analyzed by a latex agglutination method under nonreduced and unheated conditions; wherein the molecular weight of high-molecular weight adiponectin used as the antigen is higher than 670 kDa as determined by gel filtration.

2. The method according to claim 1 , the method comprising determining the molecular weight of high-molecular weight adiponectin by gel filtration with Dulbecco's phosphate buffered saline (D-PBS) as a solvent at a speed of 1 mL/minute.

3. A method for producing a monoclonal antibody, the method comprising:

immunizing a non-human animal with an antigen consisting of high-molecular weight adiponectin having a molecular weight higher than 670 kDa as determined by gel filtration together with an adjuvant, wherein the high-molecular weight adiponectin is purified from human blood;

producing hybridomas using cells from the immunized non-human animal; and

selecting a hybridoma which produces a monoclonal antibody which reacts with high-molecular weight adiponectin, does not react with trimeric adiponectin, and does not substantially react with hexameric adiponectin, when analyzed by a latex agglutination method under nonreduced and unheated conditions.

Assignments (6)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2017
From: AKAMATSU, SUGURU; KATSURAGI, KIYONORI; ONISHI, HIDEAKI; ABE, MIDORI; HADAMA, TORU
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 042048/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2017
From: NISHIMURA, AYAKO; OOGUCHI, MIO
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 042048/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2017
From: OTSUKA PHARMACEUTICAL CO., LTD.
To: LSI MEDIENCE CORPORATION
Reel/Frame 042048/0376 →
CHANGE OF NAME Recorded Apr 18, 2017
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 042282/0035 →